Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

If Maggie O'Neil can't find a match among family members, she'll have to turn to a global nonprofit that connects volunteer ...

This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

The contribution of molecular alterations in bone marrow mesenchymal stromal cells (BM-MSC) to the pathogenesis of acute myeloid leukemia (AML) is poorly understood. Thus we assessed genome-wide ...

Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML ...

A 2-year-old boy who was diagnosed with a rare and aggressive cancer has received a life-saving bone marrow donation. Hezekiah “Hezzy” Martinez received a diagnosis for acute myeloid leukemia ...